Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crucial Role of Oncogenic KRAS Mutations in Apoptosis and Autophagy Regulation: Therapeutic Implications
A I Ferreira, Flávia Pereira, Celso A. Reis, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2183-2183
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma
Yu‐Ting Xue, Xuejiao Jiang, Junrong Wang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Circular RNAs in the KRAS pathway: Emerging players in cancer progression
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155259-155259
Closed Access | Times Cited: 12
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review
Fernand Bteich, Mahshid Mohammadi, T. Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12030-12030
Open Access | Times Cited: 14
Targeting NUPR1-dependent stress granules formation to induce synthetic lethality in KrasG12D-driven tumors
Patricia Santofimia‐Castaño, Nicolás A. Fraunhoffer, Xi Liu, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 3, pp. 475-505
Open Access | Times Cited: 4
The Current Role of Circulating Tumor DNA in the Management of Pancreatic Cancer
M.C. Cox, Dominic Vitello, Akhil Chawla
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Genome‐Wide Screening in Haploid Stem Cells Reveals Synthetic Lethality Targeting MLH1 and TP53 Deficient Tumours
Rivki Cashman, Guy Haim‐Abadi, Elyad Lezmi, et al.
Cell Proliferation (2025)
Open Access
Small molecules for Kirsten rat sarcoma viral oncogene homolog mutant cancers: Past, present, and future
Peiliang Dong, Jiating Ni, Xinyue Zheng, et al.
European Journal of Pharmacology (2025), pp. 177428-177428
Closed Access
Unravelling key signaling pathways for the therapeutic targeting of non-small cell lung cancer
P. Chavan, Ruchi Pandey, BHEEMANAGOUDA O. PATIL, et al.
European Journal of Pharmacology (2025), pp. 177494-177494
Closed Access
Network pharmacology and AI in cancer research uncovering biomarkers and therapeutic targets for RALGDS mutations
S. Mohammed Zaidh, Hariharan Thirumalai Vengateswaran, Mohammad Habeeb, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Targeting KRAS-G12C in Lung Cancer: The Emerging Role of PROTACs in Overcoming Resistance
Kumarappan Chidambaram, Arcot Rekha, Ahsas Goyal, et al.
Pathology - Research and Practice (2025), pp. 155954-155954
Closed Access
Salvianolic acid F suppresses KRAS-dependent lung cancer cell growth through the PI3K/AKT signaling pathway
Xuenan Hou, Chishun Zhou, Zuhui Liang, et al.
Phytomedicine (2023) Vol. 121, pp. 155093-155093
Open Access | Times Cited: 10
Challenges and Opportunities of Gene Therapy in Cancer
Milky Mittal, Annu Kumari, Bhashkar Paul, et al.
OBM Genetics (2024) Vol. 08, Iss. 01, pp. 1-501
Open Access | Times Cited: 3
Impact of carbamazepine on SMARCA4 (BRG1) expression in colorectal cancer: modulation by KRAS mutation status
Aaron Shaykevich, Danbee Chae, Isaac Silverman, et al.
Investigational New Drugs (2024) Vol. 42, Iss. 2, pp. 229-239
Open Access | Times Cited: 3
Dual-targeted NAMPT inhibitors as a progressive strategy for cancer therapy
Fikriye Ozgencil, Habibe Beyza Gunindi, Gökçen Eren
Bioorganic Chemistry (2024) Vol. 149, pp. 107509-107509
Closed Access | Times Cited: 3
Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer
Tao Yuan, Ruilin Wu, Weihua Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Potential biomarkers uncovered by bioinformatics analysis in sotorasib resistant-pancreatic ductal adenocarcinoma
Prasanna Srinivasan Ramalingam, A. Priyadharshini, Isaac Arnold Emerson, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 7
Silver Nanoparticles with Dual-Recognition via CRISPR/dCas9 for SERS Identification of Two KRAS Mutations in Nucleic Acid Targets
Ailing Su, Yuan Liu, Weihan Sun, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 8, pp. 9800-9808
Closed Access | Times Cited: 2
Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential
Ryan N. Fuller, Ann Morcos, Joab Galvan Bustillos, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189153-189153
Open Access | Times Cited: 2
Rethinking the pathogenesis of endometriosis: Complex interactions of genomic, epigenetic, and environmental factors
Hiroshi Kobayashi, Shogo Imanaka, Chiharu Yoshimoto, et al.
Journal of Obstetrics and Gynaecology Research (2024) Vol. 50, Iss. 10, pp. 1771-1784
Open Access | Times Cited: 2
Computational design and validation of effective siRNAs to silence oncogenic KRAS
Prasanna Srinivasan Ramalingam, Sivakumar Arumugam
3 Biotech (2023) Vol. 13, Iss. 11
Open Access | Times Cited: 5
Genotoxicity and oxidative stress induction by calcium hydroxide, calcium titanate or/and yttrium oxide nanoparticles in mice
Hanan R. H. Mohamed, Ahmed H. Farouk, Salma H. Elbasiouni, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Genetic and nongenetic mechanisms for colorectal cancer evolution
Sau Yee Kok, Mizuho Nakayama, Atsuya Morita, et al.
Cancer Science (2023) Vol. 114, Iss. 9, pp. 3478-3486
Open Access | Times Cited: 4
Targeting KRAS in pancreatic adenocarcinoma: Progress in demystifying the holy grail
Ahmed Elhariri, Ahmed Alhaj, Daniel H. Ahn, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 8, pp. 285-296
Open Access | Times Cited: 4
Factors related to tumor response rate from TCGA three omics data—variants, expression, methylation
Hyung‐Min Ahn, Insu Park, Chang-Geun Kim, et al.
Journal of Environmental Science and Health Part C (2024) Vol. 42, Iss. 3, pp. 173-188
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top